- Home
- AVD vs SCPH Comparison
AVD vs SCPH Comparison
Compare AVD & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- SCPH
- Stock Information
- Founded
- AVD 1969
- SCPH 2013
- Country
- AVD United States
- SCPH United States
- Employees
- AVD N/A
- SCPH N/A
- Industry
- AVD Agricultural Chemicals
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- AVD Industrials
- SCPH Health Care
- Exchange
- AVD Nasdaq
- SCPH Nasdaq
- Market Cap
- AVD 165.8M
- SCPH 179.6M
- IPO Year
- AVD N/A
- SCPH 2017
- Fundamental
- Price
- AVD $4.80
- SCPH $3.38
- Analyst Decision
- AVD Strong Buy
- SCPH Strong Buy
- Analyst Count
- AVD 3
- SCPH 2
- Target Price
- AVD $16.67
- SCPH $15.00
- AVG Volume (30 Days)
- AVD 328.5K
- SCPH 442.5K
- Earning Date
- AVD 11-11-2024
- SCPH 11-13-2024
- Dividend Yield
- AVD 1.27%
- SCPH N/A
- EPS Growth
- AVD N/A
- SCPH N/A
- EPS
- AVD N/A
- SCPH N/A
- Revenue
- AVD $553,839,000.00
- SCPH $30,278,000.00
- Revenue This Year
- AVD N/A
- SCPH $172.64
- Revenue Next Year
- AVD $5.31
- SCPH $131.43
- P/E Ratio
- AVD N/A
- SCPH N/A
- Revenue Growth
- AVD N/A
- SCPH 303.87
- 52 Week Low
- AVD $4.26
- SCPH $3.08
- 52 Week High
- AVD $14.28
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- AVD 46.81
- SCPH 44.62
- Support Level
- AVD $4.46
- SCPH $3.27
- Resistance Level
- AVD $5.01
- SCPH $3.58
- Average True Range (ATR)
- AVD 0.24
- SCPH 0.19
- MACD
- AVD 0.06
- SCPH 0.01
- Stochastic Oscillator
- AVD 72.00
- SCPH 22.92
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.